RecruitingNCT02198976
Australian Barrett's Cohort With Dysplasia and Early Cancer Study
Sponsor
Professor Michael Bourke
Enrollment
300 participants
Start Date
Apr 1, 2014
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to collect prospective observational data regarding endoscopic management and outcomes of patients with Barrett's oesophagus (BO) with high grade dysplasia and/or intramucosal carcinoma. To observe the natural history of patients with low grade dysplastic and non dysplastic Barrett's oesophagus
Eligibility
Min Age: 18 YearsMax Age: 99 Years
Inclusion Criteria3
- Can give informed consent to trial participation
- Age greater than 18
- Barrett's oesophagus
Exclusion Criteria2
- Age less than 18
- Pregnant patients
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02198976
Related Trials
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
NCT065233749 locations
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
NCT029479711 location
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT0028811910 locations
Navicam for Detection of Barrett's Esophagus
NCT067489111 location
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
NCT026346454 locations